Robert Shawah
Founder at ACURX PHARMACEUTICALS, INC.
Net worth: 382 184 $ as of 2024-04-29
Robert Shawah active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ACURX PHARMACEUTICALS, INC. | Founder | 2017-06-30 | - |
| Director of Finance/CFO | 2017-06-30 | - | |
| Comptroller/Controller/Auditor | 2017-06-30 | - |
Career history of Robert Shawah
Former positions of Robert Shawah
| Companies | Position | Start | End |
|---|---|---|---|
Ameri100 Holdco, Inc.
 Ameri100 Holdco, Inc. MiscellaneousMiscellaneous Ameri100 Holdco, Inc. operates as an investment holding company. The company is headquartered in Delaware. | Director/Board Member | 2018-07-31 | 2018-11-30 |
Dipexium Pharmaceuticals, Inc.
 Dipexium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dipexium Pharmaceuticals, Inc. is a late stage pharmaceutical company, which is focused on the development and commercialization of Locilex, a potent and broad spectrum topical antibiotic peptide for the treatment of mild and moderate skin and skin structure infections. The company was founded by Robert J. DeLuccia and David P. Luci on January 14, 2010 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 2014-02-28 | 2017-03-31 |
| Treasurer | 2014-02-28 | 2017-03-31 | |
| Baldwin Pearson & Co., Inc. | Corporate Officer/Principal | 2004-12-31 | 2012-12-31 |
Training of Robert Shawah
| Bucknell University | Undergraduate Degree |
Statistics
International
| United States | 6 |
Operational
| Comptroller/Controller/Auditor | 2 |
| Treasurer | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ACURX PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Dipexium Pharmaceuticals, Inc.
Dipexium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dipexium Pharmaceuticals, Inc. is a late stage pharmaceutical company, which is focused on the development and commercialization of Locilex, a potent and broad spectrum topical antibiotic peptide for the treatment of mild and moderate skin and skin structure infections. The company was founded by Robert J. DeLuccia and David P. Luci on January 14, 2010 and is headquartered in New York, NY. | Health Technology |
Ameri100 Holdco, Inc.
Ameri100 Holdco, Inc. MiscellaneousMiscellaneous Ameri100 Holdco, Inc. operates as an investment holding company. The company is headquartered in Delaware. | Miscellaneous |
| Baldwin Pearson & Co., Inc. |
- Stock Market
- Insiders
- Robert Shawah
- Experience
